Secondary

9 clinical trials · Condition

Record	Firm	Date
Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC (NCT03226236)	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	2016-03-01
Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression (NCT02919462)	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	2016-03-01
Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC) (NCT02716766)	The University of Hong Kong	2016-03-01
MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate (NCT02067143)	Gruppo Italiano Malattie EMatologiche dell'Adulto	2014-05-20
Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients (NCT01420146)	Jules Bordet Institute	2011-08-01
A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy (NCT00506207)	National Cancer Center, Korea	2006-09-01
Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan (NCT00507143)	National Cancer Center, Korea	2006-08-01
Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer (NCT00506168)	National Cancer Center, Korea	2001-11-01

Track Secondary automatically

Every clearance here is in the API, with alerts when new ones post.